Pandemic influenza vaccine

Nasjonalt folkehelseinstitutt

The Norwegian Institute of Public Health (NIPH), on behalf of the Norwegian Ministry of Health and Care Services, will conduct a competitive dialogue for procurement of pandemic influenza vaccine to the Norwegian population. The purpose of this tender is to ensure that the inhabitants of Norway have access to vaccine in case of a possible pandemic influenza throughout the agreement period. The awarded contracts will contain an option for delivery of pandemic influenza vaccine in the agreement period. The viral component must be in accordance with the recommendations made by the WHO. The total volume will cover full immunization of up to 5-5 500 000 people (the Norwegian population at the time of delivery). The number of doses ordered by the NIPH from each supplier in case of an outbreak will be dependent on the chosen immunization regime and the expected severity of the pandemic. NIPH's preliminary intention is to enter into agreements with two suppliers in order to ensure the best possible security of supply. In addition to the primary obligation comprising manufacturing and supply of the vaccines, and subject to separate remuneration, both suppliers shall reserve production capacity adequate to fulfil their delivery obligations under the agreements. In order to establish a complete set of terms and conditions for the competition and the delivery agreements in accordance with what the market operators are able to meet, NIPH is dependent on further information from potential suppliers. NIPH is i.e. dependent on further information regarding possible delivery time, doses and packaging. Considering that NIPH is currently not able to establish a complete set of tender documents, the procurement will be conducted as a competitive dialogue. By documenting the fulfilment of the qualification criteria in the current invitation, suppliers will be qualified and invited to further participation in the dialogue.
Note: To register your interest in this notice and obtain any additional information please visit the Doffin Web Site at: http://www.doffin.no/Search/Search_Switch.aspx?ID=299620.

Frist

Fristen for mottak av tilbud var 2013-08-23. Anskaffelsen ble publisert 2013-07-04.

Leverandører

Følgende leverandører er nevnt i tildelingsbeslutninger eller andre anskaffelsesdokumenter:

Hvem? Hva? Hvor?
Anskaffelseshistorikk
Dato Dokument
2013-07-04 Kunngjøring av konkurranse
2014-09-11 Kunngjøring om tildeling av kontrakt
Kunngjøring av konkurranse (2013-07-04)
Gjenstand
Anskaffelsens omfang
Tittel: Vaccines
Antall eller omfang:
The total volume will cover full immunization of up to 5-5 500 000 people (the Norwegian population at the time of delivery).
Metadata for kunngjøring
Originalspråk: engelsk 🗣️
Dokumenttype: Kunngjøring av konkurranse
Kontraktens art: Varer
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS), med deltakelse av GPA-land
Felles innkjøpsordliste (CPV)
Kode: Vaksiner 📦

Prosedyre
Prosedyretype: Konkurransepreget dialog
Tilbudstype: Innlevering for alle delkontrakter
Tildelingskriterier
Det mest økonomisk fordelaktige tilbudet

Oppdragsgiver
Identitet
Land: Norge 🇳🇴
Type tildelende myndighet: Departement eller annen nasjonal eller føderal myndighet
Navn på tildelende myndighet: Nasjonalt folkehelseinstitutt
Postadresse: Lovisenberggata 8
Postnummer: 0456
Poststed: Oslo
Kontakt
Internettadresse: http://www.fhi.no/ 🌏
E-post: ole.andreas.fuglesang@fhi.no 📧
Telefon: +47 21076629 📞

Referanse
Datoer
Sendt dato: 2013-07-04 📅
Innleveringsfrist: 2013-08-23 📅
Publiseringsdato: 2013-07-09 📅
Identifikatorer
Kunngjøringsnummer: 2013/S 131-227525
OJ-S-utgave: 131
Tilleggsinformasjon
Subject to the Norwegian Institute of Public Health's reservations regarding translation errors in the tender notice (NT Ref:299870) IV.3.6) Language(s) in which tenders or requests to participate may be drawn up Other: Norwegian.

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
The Norwegian Institute of Public Health (NIPH), on behalf of the Norwegian Ministry of Health and Care Services, will conduct a competitive dialogue for procurement of pandemic influenza vaccine to the Norwegian population. The purpose of this tender is to ensure that the inhabitants of Norway have access to vaccine in case of a possible pandemic influenza throughout the agreement period. The awarded contracts will contain an option for delivery of pandemic influenza vaccine in the agreement period. The viral component must be in accordance with the recommendations made by the WHO. The total volume will cover full immunization of up to 5-5 500 000 people (the Norwegian population at the time of delivery). The number of doses ordered by the NIPH from each supplier in case of an outbreak will be dependent on the chosen immunization regime and the expected severity of the pandemic. NIPH's preliminary intention is to enter into agreements with two suppliers in order to ensure the best possible security of supply. In addition to the primary obligation comprising manufacturing and supply of the vaccines, and subject to separate remuneration, both suppliers shall reserve production capacity adequate to fulfil their delivery obligations under the agreements. In order to establish a complete set of terms and conditions for the competition and the delivery agreements in accordance with what the market operators are able to meet, NIPH is dependent on further information from potential suppliers. NIPH is i.e. dependent on further information regarding possible delivery time, doses and packaging. Considering that NIPH is currently not able to establish a complete set of tender documents, the procurement will be conducted as a competitive dialogue. By documenting the fulfilment of the qualification criteria in the current invitation, suppliers will be qualified and invited to further participation in the dialogue.
Vis mer
Note: To register your interest in this notice and obtain any additional information please visit the Doffin Web Site at: http://www.doffin.no/Search/Search_Switch.aspx?ID=299620.
Beskrivelse av opsjoner: The contract includes option for delivery of pandemic influenza vaccine.
Varighet: 48 måneder
Referansenummer: 13/1183
Utførelsessted
Hovedsted eller utførelsessted: Oslo, Norway.

Juridisk, økonomisk, finansiell og teknisk informasjon
Vilkår for deltakelse
Egnethet til å utøve yrkesvirksomheten:
(1) Other documentation required (please state below)
See the tender invitation documents.
Økonomisk og finansiell stilling:
(1) Other documentation required (please state below)
See the tender invitation documents.
Teknisk og faglig kapasitet:
(1) Other documentation required (please state below)
See the tender invitation documents.
Kontraktutførelse
Andre særlige vilkår: See the tender invitation documents.

Prosedyre
Minste antall kandidater: 3
Største antall kandidater: 10
Objektive utvelgelseskriterier: All qualified participants are invited to the dialogue.
Dato for utsendelse av invitasjoner: 2013-09-02 📅
Språk
Språk: engelsk 🗣️

Oppdragsgiver
Identitet
Navn på tildelende myndighet: The Ministry of Health and Care Services
Kontakt
Kontaktpunkt: Innkjøp
Ole Andreas Fuglesang
Adresse til kjøperprofilen: http://www.doffin.no//search/Search_AuthProfile.aspx?ID=AA0198 🌏

Referanse
Identifikatorer
Referansenummer tildelt av oppdragsgiver: 13/1183
Tilleggsinformasjon
Subject to the Norwegian Institute of Public Health's reservations regarding translation errors in the tender notice
(NT Ref:299870)
IV.3.6) Language(s) in which tenders or requests to participate may be drawn up
Other:
Norwegian.
Kilde: OJS 2013/S 131-227525 (2013-07-04)
Kunngjøring om tildeling av kontrakt (2014-09-11)
Gjenstand
Anskaffelsens omfang
Tittel: Influenza vaccines
Totalverdi for anskaffelsen: 900 000 000 💰
Metadata for kunngjøring
Dokumenttype: Kunngjøring om tildeling av kontrakt
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS)
Felles innkjøpsordliste (CPV)
Kode: Influensavaksine 📦

Prosedyre
Tilbudstype: Ikke aktuelt

Oppdragsgiver
Identitet
Type tildelende myndighet: Ikke spesifisert
Kontakt
Internettadresse: http://www.fhi.no 🌏
Telefon: +47 21077000 📞

Referanse
Datoer
Sendt dato: 2014-09-11 📅
Publiseringsdato: 2014-09-16 📅
Identifikatorer
Kunngjøringsnummer: 2014/S 177-313698
Refererer til kunngjøring: 2013/S 131-227525
OJ-S-utgave: 177

Prosedyre
Tildelingskriterier
Kriterium: 1. Quality (40)
2. Punctuality and capacity (25)
3. Price (20)
4. Flexibility (10)
5. Level of service (5)

Tildeling av kontrakt

1️⃣
Dato for kontraktinngåelse: 2014-03-07 📅
Navn: GlaxoSmithKline AS
Postadresse: Postboks 180 Vinderen
Poststed: Oslo
Postnummer: 0319
Land: Norge 🇳🇴

2️⃣
Navn: Novartis Norge AS
Postadresse: P.O. Box 4284 Nydalen
Postnummer: 0401
Informasjon om tilbud
Antall mottatte tilbud: 2

Oppdragsgiver
Identitet
Nasjonalt registreringsnummer: 983744516
Kontakt
URL for dokumenter: https://kgv.doffin.no/ctm/Supplier/Documents/Folder/8313 🌏
Kilde: OJS 2014/S 177-313698 (2014-09-11)
Nye anskaffelser i relaterte kategorier 🆕
Relaterte søk 🔍
Region:
Norge Norge
Leverandører:
GlaxoSmithKline AS Novartis Norge AS
Produkter/tjenester:
Medisinsk utstyr, legemidler og utstyr... Farmasøytiske produkter Antiinfektive midler for systemisk bruk,... Antiinfektive midler for systemisk bruk Vaksiner Influensavaksine